Research & Development: Page 75

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive Appointments and Promotions Pharma POOL Dr. Corey Goodman Dr. Martin Mackay Dr. Briggs Morrison Pfizer Announces Executive Changes Pfizer has launched an independent, stand-alone biotherapeutics and bioinnovation center under the direction of scientist and entrepreneur Corey Goodman, Ph...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Internationally renowned vaccines, immunology, and virology expert Paul A. Offit, M.D., has dedicated his career to discovering vaccines to prevent infectious diseases, and is the co-inventor of the rotavirus vaccine, RotaTeq, developed by Merck. A pediatrician, author, and scientific researcher,...

    By PharmaVoice Team • Jan. 2, 2008
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies Thomson Scientific Offers Data Platform for Researchers Thomson Scientific has released BONDplus, an integrated, Web-based data platform designed to deliver real-time, comprehensive public and proprietary biological sequence, inte...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New Healthcare-related Products, Services, and Companies inVentiv Health Creates Patient Outcomes Segment New division combines capabilities that help patients achieve optimum health. inVentiv Health has launched inVentiv Patient Outcomes, a business segment focused on helping pharmaceutical comp...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    Industry Events January 2008 January 15-16 2nd Annual Medical Science Liaison Skill Set Training Doubletree Hotel Philadelphia, Philadelphia For more information, contact Andrea Chadis, Center for Business Intelligence, at 781-939-2428, e-mail [email protected], or visit cbinet.com. January 15-...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Analysts Pharmacists Could Impact $145 Billion in Drug Sales in Five Years One state, Florida, already allows pharmacists to independently prescribe prescription drugs, and new research suggests six other states may soon give pharmacists this pow...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    When the Stars Align

    By Robin Robinson The practice of using celebrities in marketing campaigns has not lost its luster, but the pharma industry is more selective in choosing icons who match brand images. As the industry approaches the 10th anniversary of the FDA’s ruling to allow DTC and subsequently the industry’s ...

    By Robin Robinson • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Human Resource Related Issues

    Otuska America Pharmaceutical’s Lorraine Daly, Leslie Eggleston, and Richard Obring discuss how HR issues, including compliance, compensation, and staffing can impact a pharmaceutical company’s culture. Otsuka’s Human Resources Department is responsible for more than 600 Otsuka employees in the U...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaOutlet

    Contributed by Craig A. DeLarge Craig A. DeLarge discusses Web 2.0’s drawbacks and opportunities. January 2008 Web 2.0 — Opportunities and Drawbacks n the last month, I have been intensely researching the Web 2.0 phenomenon with respect to its healthcare manifestations. This research has involved...

    By Craig A. DeLarge • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Finding the Right Path -- Jane Hollingsworth

    NuPathe cofounder and CEO Jane Hollingsworth has a fearless attitude about the risks involved in starting and running a business — and defines what it means to be an entrepreneur. Competitive by nature and with a fearless attitude when it comes to the risks involved in starting and running a busi...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    By Taren Grom, Editor I’m getting ready for Web. 2.0. Is your avatar up to date and ready to navigate the “new” World Wide Web? Web 2.0, social networking, or as the contributing author of this month’s Outlet refers to the recent phenomenon “the collective Web,” is seemingly on the tip of everyon...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Milestones In More than 1 Million Served InfoMedics Inc. recently reached a set of significant milestones, including the enrollment of the 1 millionth patient and 500,000th physician in the course of implementing more than 150 patient-physician communications programs for 14 of the top 15 pharmac...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Delivering New Hope

    In a bid to tackle patient compliance, improve treatments, and maximize drug sales, companies are increasingly looking to emerging drug delivery technologies. By Kim Ribbink Necessity is the mother of invention. In the pharmaceutical industry “necessity” might be characterized as patent expiratio...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Doctors' Choice Awards

    The doctors’ choice awards, an annual study conducted by the Association of Medical Media (formerly the Association of Medical Publications), is the only program that is voted on by the industry’s customers — the physicians. Winners are selected according to their scores in an independent Interne...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    What’s New New Healthcare-related Products, Services, and Companies CommonHealth Seeks to Enhance Healthcare with Launch of EvoLogue The agency is focusing on evolving the healthcare dialogue. CommonHealth Consumer Group (CCG) has launched EvoLogue, a full-service consumer agency providing insigh...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    New Worlds of Opportunities Clinical Development

    By Denise Myshko Technology will be the change agent for overhauling development processes to reduce costs and increase efficiencies. The development process needs to undergo a major overhaul to reduce costs and increase efficiencies to bring new medicines to market in a more timely manner. The c...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Medicare Part D

    Industry experts evaluate the impact of Medicare Part D and project what further market- shaping events are to come. For consumers, the implementation of Medicare Part D has mostly been positive — reduced out-of-pocket costs and improved access to medicines. According to a study by The Amundsen G...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    An Industry Overview

    BY ROBIN ROBINSON The strategic plans for 2008 in the industry appear to be business as usual, which may not bode well for its future, according to PricewaterhouseCoopers’ (PWC) latest report. According to Pharma 2020: The Vision report, to make the most of future growth opportunities, the indust...

    By Robin Robinson • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise Your Voice -- Letters

    Flawless Execution The most successful brand and product managers are the ones who look to their suppliers as partners rather than just “vendors” of a narrowly defined product or service. Kathleen A. Bonetti VP of Marketing LeveragePoint Media/Rx EDGE Raise Your Voice — Letters More than a vendor...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Stem Cells

    By Kim Ribbink Experts discuss the milestones that have been achieved and the implications for stem-cell therapeutics. The Stem of Hope New findings and understandings about the way stem cells operate and their potential in therapeutic development have led to real hope that there could soon be tr...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Then & Now

    Thought leaders review their 2006 predictions in 2007. PharmaVOICE asked experts who participated in last year’s issue to review their predictions for 2007 and evaluate whether their forecasts came to fruition and why or why not. (Editor’s Note: Predictions are presented in alphabetical order by ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Basic Research

    New tools and technologies will provide new ways of looking at diseases, which could lead to a pipeline of new products. Start with the end in mind: patients. Leaders in drug discovery and research say this should guide how the biopharmaceutical industry approaches new medicines now and in the fu...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies Verispan and Marketing Technology Solutions (MTS) have launched Brand Sig, a tool that integrates patient perceptions with prescription information to provide insights into what causes patients to fill, or not fill, prescriptions....

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Information Solutions to Provide New Impact on Clinical and Financial Goals

    Information Solutions to Provide New Impact on Clinical and Financial Goals Dale Danilewitz, Chief Information Officer Our need for immediate information is met at every turn. Stock tickers and news crawlers bring us the latest updates as they happen. Resources such as Google and Wikipedia ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Crystal Ball

    Industry experts identify the top trends they expect to shape the industry. We asked our industry experts to identify the top trends that they expect to shape the industry in the coming year and beyond. Some of their responses may surprise you; others may already be on your radar. You may agree w...

    By PharmaVoice Team • Jan. 2, 2008